罕见病用药医保准入标准偏好选择研究:基于医保专家视角
邵家琛, 李顺平, 陈敬丹, 袁佳麒, 李林康
Preference study on medical insurance access criteria for rare disease medications: based on the perspective of medical insurance experts
Shao Jiachen, Li Shunping, Chen Jingdan, Yuan Jiaqi, Li Linkang
健康发展与政策研究
.
2026, (4): 639
-646
.
DOI: 10.12458/HDPR.202509004